BioCentury
ARTICLE | Company News

Curemark begins rolling NDA for autism product

November 5, 2013 2:03 AM UTC

Curemark LLC (Rye, N.Y.) began submission of a rolling NDA to FDA for CM-AT to treat autism. The product is a powder formulation of an undisclosed enzyme that is released in the small intestine to aid...